IP Library › Assignment 050642/0074
Patent Assignment
Reel/Frame 050642/0074

Security Interest

Recorded: 2019-10-07 Pages: 15
Assignor
VELICEPT THERAPEUTICS, INC.
Executed: 2019-10-04
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
133 NORTH FAIRFAX STREET, ALEXANDRIA, VIRGINIA, 22314
Covered Properties (40)
Chemical compounds
Application: 11/358,601 →
Publication: US 2006/0148887
Pharmaceutical Combination
Application: 61/370,171 →
Pharmaceutical Combinations
Application: 61/596,893 →
Method of Using Solabegron
Application: 15/235,720 →
Publication: US 2017/0035716
Pharmaceutical Combinations
Application: 62/020,889 →
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 62/087,021 →
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 15/951,953 →
Publication: US 2019/0083433
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 15/951,968 →
Publication: US 2019/0083434
Dosing Regimens for Beta-3 Adrenoceptor Agonists and Anti-Muscarinic Agents for the Treatment and Prevention of Lower Urinary Tract Symptoms and Overactive Bladder
Application: 15/614,531 →
Publication: US 2017/0348288
Compositions and Methods of Using Modified Release Beta-3 Adrenoceptor Agonists for Lower Urinary Tract Symptoms
Application: 62/345,283 →
Dosing Regimens for Beta-3 Adrenoceptor Agonists and Anti-Muscarinic Agents for the Treatment and Prevention of Lower Urinary Tract Symptoms
Application: 62/345,655 →
Solabegron Zwitterion and Uses Thereof
Application: 62/245,656 →
Solabegron Zwitterion and Uses Thereof
Application: 62/245,670 →
Solabegron Zwitterion and Uses Thereof
Application: 62/345,327 →
Solabegron Zwitterion and Uses Thereof
Application: 16/246,114 →
Publication: US 2019/0185414
Solabegron Zwitterion and Uses Thereof
Application: 62/345,357 →
Processes for Making Solabegron
Application: 62/345,574 →
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 62/345,388 →
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 15/614,577 →
Publication: US 2017/0348263
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 62/345,519 →
Medical Use for Atypical Bta Adrenoceptor Agonists
Patent: 6,696,486 →
Application: 08/601,442 →
Therapeutic biaryl derivatives
Patent: 6,251,925 →
Application: 09/719,595 →
Process for the Preparation of Arylethanolamine Derivatives Having an Anti-Obesity and Anti-Diabetic Properties
Patent: 6,548,523 →
Application: 10/148,841 →
Publication: US 2002/0198220
Phenethanolamine Derivatives, Compositions, and Their Use as Agonists at Atypical Beta-Adrenoreceptors
Patent: 7,034,053 →
Application: 10/470,860 →
Publication: US 2004/0106672
Process
Patent: 7,425,639 →
Application: 10/470,907 →
Publication: US 2004/0077868
Process of Preparing Arylethanoldiamines
Patent: 7,709,677 →
Application: 12/189,941 →
Publication: US 2008/0306278
Pharmaceutical Combinations of Beta-3 Adrenergic Receptor Agonists and Muscarinic Receptor Antagonists
Patent: 8,642,661 →
Application: 13/196,068 →
Publication: US 2012/0035118
Pharmaceutical Combination
Patent: 9,522,129 →
Application: 13/762,563 →
Publication: US 2013/0172277
Pharmaceutical Compositions and the Treatment of Overactive Bladder
Patent: 9,907,767 →
Application: 15/323,685 →
Publication: US 2017/0151199
Pharmaceutical Compositions and the Treatment of Overactive Bladder
Application: 15/868,582 →
Publication: US 2018/0147169
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Patent: 9,956,194 →
Application: 14/958,610 →
Publication: US 2016/0158176
Solabegron Zwitterion and Uses Thereof
Application: 15/332,956 →
Publication: US 2017/0114005
Solabegron Zwitterion and Uses Thereof
Application: 16/018,945 →
Publication: US 2018/0370902
Pharmaceutical Combinations
Pharmaceutical Combination
Pharmaceutical Combinations
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Dosing Regimens for Beta-3 Adrenoceptor Agonists and Anti-Muscarinic Agents for the Treatment and Prevention of Lower Urinary Tract Symptoms and Overactive Bladder
Solabegron Zwitterion and Uses Thereof
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 13, 2002
From: DEATON, DAVID NORMAN
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 012639/0601 →
Assignment of Assignor's Interest Jul 8, 2002
From: LAWRENCE, RONNIE MAXWELL
To: GLAXO WELLCOME, INC.
Reel/Frame 013070/0724 →
Merger Jul 8, 2002
From: GLAXO WELLCOME INC.
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 013070/0763 →
Merger Mar 19, 2008
From: GLAXO WELLCOME INC
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 020666/0598 →
Change of Name Mar 19, 2008
From: GLAXO WELLCOME INC
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 020666/0578 →
Change of Name Jun 22, 2011
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 026503/0852 →
Assignment of Assignor's Interest Jul 25, 2011
From: GLAXOSMITHKLINE LLC
To: ALTHERX, INC.
Reel/Frame 026640/0943 →
Assignment of Assignor's Interest Sep 22, 2011
From: GLAXO GROUP LIMITED
To: ALTHERX, INC.
Reel/Frame 026947/0271 →
Assignment of Assignor's Interest Oct 13, 2011
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 027055/0757 →
Assignment of Assignor's Interest Oct 3, 2013
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 031336/0689 →
Assignment of Assignor's Interest Dec 15, 2014
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 034505/0095 →
Assignment of Assignor's Interest Dec 15, 2014
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 034505/0140 →
Assignment of Assignor's Interest Nov 6, 2015
From: STEVENS, RAYMOND E., JR
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 036978/0275 →
Assignment of Assignor's Interest Nov 6, 2015
From: STEVENS, RAYMOND E., JR
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 036978/0493 →
Assignment of Assignor's Interest Nov 10, 2015
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 036999/0663 →
Assignment of Assignor's Interest Nov 10, 2015
From: OHLSTEIN, ELIOT; STEVENS, RAYMOND E., JR.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 036999/0486 →
Assignment of Assignor's Interest Nov 10, 2015
From: WILKINS, H. JEFFREY
To: NST CONSULTING, LLC
Reel/Frame 036999/0589 →
Assignment of Assignor's Interest Nov 10, 2015
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 037001/0974 →
Assignment of Assignor's Interest Sep 2, 2016
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 039621/0163 →
Assignment of Assignor's Interest Mar 9, 2017
From: ALTHERX, INC.
To: VELICEPT THERAPEUTIS, INC.
Reel/Frame 041526/0441 →
Assignment of Assignor's Interest Dec 19, 2017
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 044440/0741 →
Assignment of Assignor's Interest Dec 19, 2017
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044440/0841 →
Assignment of Assignor's Interest Jan 10, 2018
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0692 →
Assignment of Assignor's Interest Jan 10, 2018
From: OHLSTEIN, ELIOT
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044584/0146 →
Assignment of Assignor's Interest Jan 10, 2018
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044587/0747 →